Hotta et al., 1986 - Google Patents
Lipopolysaccharide-induced colitis in rabbitsHotta et al., 1986
- Document ID
- 134385848160154529
- Author
- Hotta T
- Yoshida N
- Yoshikawa T
- Sugino S
- Kondo M
- Publication year
- Publication venue
- Research in experimental medicine
External Links
Snippet
An experimental animal model of human ulcerative colitis using lipopolysaccharide (LPS) was studied. Rabbits were skin-sensitized by LPS and challenged with intrarectal instillation of LPS after 1% formalin enema. The course of experimental colitis was followed by …
- 239000002158 endotoxin 0 title abstract description 76
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sakai et al. | Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis | |
Le Quintrec et al. | Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy | |
Rubin et al. | Immunofluorescent studies in adult celiac disease | |
Raqib et al. | Persistence of local cytokine production in shigellosis in acute and convalescent stages | |
Kwak et al. | Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology | |
Håversen et al. | Anti‐inflammatory activities of human lactoferrin in acute dextran sulphate‐induced colitis in mice | |
McCarthy et al. | Selective IgA deficiency associated with total villous atrophy of the small intestine and an organ-specific anti-epithelial cell antibody | |
Spiegelberg et al. | The effect of 6-mercaptopurine and aminopterin on experimental immune thyroiditis in guinea pigs | |
Hotta et al. | Lipopolysaccharide-induced colitis in rabbits | |
Van den Wall Bake et al. | Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA | |
JP2010195710A (en) | Amyloid fibril formation inhibitor and use thereof | |
Walzer et al. | Humoral immunity in experimental Pneumocystis carinii infection. I. Serum and bronchial lavage fluid antibody responses in rats | |
Swerdlow et al. | Patterns of IgA deposition in liver tissues in alcoholic liver disease | |
LANGE et al. | The Congenital Nephrotic Syndrome: An Immune Reaction? | |
Borel et al. | Treatment of lupus nephritis in adult (NZB+ NZW) F1 mice by cortisone-facilitated tolerance to nucleic acid antigens. | |
Silver et al. | Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies | |
Leslie et al. | Secretory Immunological System of Fowl: V. The Gallbladder: An Integral Part of the Secretory Immunological System of Fowl | |
Snook et al. | Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis. | |
Hodgson et al. | The humoral immune system in inflammatory bowel disease: II. Immunoglobulin levels | |
Shichijo et al. | Antibody to eosinophil cationic protein suppresses dextran sulfate sodium-induced colitis in rats | |
Gris et al. | Antiglomerular basement membrane nephritis induced by IgA1 antibodies | |
Cinader et al. | Tolerance-mediated inheritance of immune responsiveness | |
RU2160445C2 (en) | Antibodies against allogenic and xenogenic proteins, their application in therapy and making diagnosis, method for determining them | |
Chiu et al. | Antigenic changes in nuclear chromatin in 1, 2‐dimethylhydrazine‐induced colon carcinogenesis | |
Hunneyball | Some further effects of prednisolone and triamcinolone hexacetonide on experimental arthritis in rabbits |